Israel: A Goliath In Middle East Science

Israel clearly dominates the entire region. It produced about 62% (some 19,000 of 30,700) of all Middle Eastern science articles indexed on SciSearch since 1987. The next biggest producer has been Egypt, with a 15% share, followed by Saudi Arabia with 10%, Kuwait with 4%, Iraq with 3%, and Jordan with a 2% share. All other countries contrib uted 1% or less of all Middle Eastern papers. In this group, Kuwait is perhaps the big surprise. The tiny nation has published about 1,200 papers in SciS

| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

Israel clearly dominates the entire region. It produced about 62% (some 19,000 of 30,700) of all Middle Eastern science articles indexed on SciSearch since 1987. The next biggest producer has been Egypt, with a 15% share, followed by Saudi Arabia with 10%, Kuwait with 4%, Iraq with 3%, and Jordan with a 2% share. All other countries contrib uted 1% or less of all Middle Eastern papers.

In this group, Kuwait is perhaps the big surprise. The tiny nation has published about 1,200 papers in SciSearch-indexed journals over, the last three years—almost half as many as the relative giant Saudi Arabia.

Each of the big three producers— Israel, Egypt, and Saudi Arabia—exhibits different strengths. Israel is particularly strong in clinical medicine and biomedical research; it also produces a relatively large number of math and computer science papers (about a 4% world share). Egypt’s chief focus is chemistry and chemical engineering, ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies